Freyr Announces a Multi-Year Strategic Partnership with Famar Group for Regulatory Submissions & Pub

Contact Us
Freyr Solutions Inc
150 College Road West, Ste 102, Princeton NJ – 085
NJ 08540 

“New Jersey – Aug 03, 2022: Freyr, one of the largest global Regulatory solutions and services providers, recently announced that Famar a leading European pharmaceutical manufacturing company with a legacy of 70 years of expertise – has selected Freyr SUBMIT PRO, a Regulatory publishing & submissions solution for market entry registrations and lifecycle management.

Freyr SUBMIT PRO enables pharmaceutical companies to quickly compile, validate, publish, and manage the eCTD submission process. It reduces the publishing efforts and improves the productivity and quality of publishing documents. Various inbuilt capabilities like eCTD validator, eCTD viewer, module cloning, and seamless integration with major DMS help in easy data transfer.

The eCTD solution aesthetically brings the automation capabilities and effectively reduces the time spent on Document Level Publishing (DLP) & Submission Level Publishing (SLP) activities. Considering Freyr SUBMIT PRO’s latest technological features and robust mechanisms to manage the submission process, Famar has announced a multi-year strategic partnership with Freyr.

“Freyr is pleased to be chosen as a preferred Publishing & Submission Management partner for Famar. The fact that we have been selected for a multi-year strategic partnership by a company with over 70 years of pharma manufacturing & development expertise comes as a strong testimony to our proven expertise in Regulatory software support to the Life Sciences industry. We are positive that this partnership will add tremendous value and enhancements to the submission process at Famar,” said Rajiv Rangan, Co-CEO, Freyr.

FAMAR is a European contract manufacturing and development organization serving the pharmaceutical industry. The company has a 70-year track record of delivering quality and value to customers across all finished dosage forms, including sterile liquids, solids, and semi-solids. FAMAR has a workforce of 1,850 employees across a network of six manufacturing sites and two R&D centers in Spain, Italy, and Greece. FAMAR currently supplies 1,700 different products to more than 80 international markets.”